Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.2M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
18.2M
-
Shares change
-
-929K
-
Total reported value, excl. options
-
$25.3M
-
Value change
-
-$1.29M
-
Number of buys
-
10
-
Number of sells
-
-9
-
Price
-
$1.39
Significant Holders of IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) as of Q2 2025
27 filings reported holding IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.2M shares
of 68.2M outstanding shares and own 26.64% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (6.17M shares), NOVO HOLDINGS A/S (3.35M shares), MARSHALL WACE, LLP (2.11M shares), PFM Health Sciences, LP (1.97M shares), BANK OF AMERICA CORP /DE/ (1.62M shares), Pivotal bioVenture Partners Investment Advisor LLC (864K shares), MORGAN STANLEY (654K shares), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (347K shares), Dauntless Investment Group, LLC (324K shares), and Soleus Capital Management, L.P. (193K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.